Xenotransplantation specialists Living Cell Technologies (LCT) have announced promising results from a Phase II clinical trial of its cell implant in diabetes patients in New Zealand.

Lancet reports on what a whole genome sequence revealed – a lot but not much.

A new treatment prevents type 1 diabetes in mice by turning the immune system on itself

Xenotransplant specialists have the go-ahead from New Zealand to begin a phase II trial of its encapsulated insulin-producing pig cells to treat diabetes.

Russian regulators have approved Living Cell Technologies’ encapsulation device that
places insulin producing cells from a pig into the human patient to treat type 1 diabetes.

A simple pair of contact lenses may alleviate the need for diabetics to regularly draw blood to test their glucose levels.

Preclinical trial results in mice show that a proprietary adult stem cell platform could be an effective treatment for diabetes.

Researchers have developed therapies that increase blood flow, improve movement and decrease tissue death and the need for amputation, a procedure that could benefit diabetics.

University of Maryland: Scientists are using the fruit fly to find the genes and gene pathways that lead to insulin resistance and diabetes in humans.